SPRINT — Sprint Bioscience AB Share News
0.000.00%
Last trade - 00:00- SEK352.42m
- SEK259.16m
- SEK167.17m
Brief: Sprint Bioscience Q3 Operating Loss Widens To SEK 8.9 Mln
Brief: Sprint Bioscience Q2 Operating Result Swings To Loss Of SEK 9.7 Mln
Brief: Sprint Bioscience Q1 Operating Profit Rises To SEK 7.3 Million
Brief: Sprint Bioscience Gets Proceeds Of About SEK 37.9 Mln Before Issue Costs In Rights Issue
Brief: Sprint Bioscience Q4 Operating Result Swings To Loss Of SEK 7.2 Million
Brief: Sprint Bioscience: Petra Pharma Applies For Three Patents For PIP4K2
Brief: Sprint Bioscience Proposes Rights Issue Of About SEK 37.9 Million
Brief: Sprint Bioscience Extend Cooperation With Petra Pharma
Brief: Sprint Bioscience: inhibition of autophagy with SB02024 activates immune system in tumor
Brief: Sprint Bioscience Q2 operating profit falls to SEK 1.0 mln
Brief: Sprint Bioscience Q4 operating result swings to profit of SEK 2.7 mln
Brief: Sprint Bioscience starts a collaboration at Laboratory of Experimental Cancer Research
Brief: Sprint Bioscience Q3 operating result turns to profit of SEK 0.5 mln
Brief: Sprint Bioscience Q2 operating result swings to profit SEK 4.1 mln
SoftBank's ARM buy may net bankers $120 million in fees (updated)
Brief: Sprint Bioscience signs licence agreement for PIP4K2-program
Brief: Sprint Bioscience: Agreement on research cooperation with HERM
Brief: Sprint Bioscience Q1 operating loss narrows to SEK 2.8 million
Brief: Sprint Bioscience will move from First North to First North Premier